Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Statins and cancer risk
Your Article Summary
Trastuzumab in the Adjuvant Treatment of Early-Stage Breast Cancer: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
The Oncologist, 07/03/08
Dahabreh IJ et al. - The use of trastuzumab should be considered an integral part of the adjuvant therapy of HER-2–positive breast cancer patients.
| Next Article |
Today in Chemotherapy/Oncology...keeping you current
Receive free subspecialty "5-minute updates" via email
Placebo-controlled phase III trial of patient-specific immunotherapy with mitumprotimut-T and granulocyte-macrophage colony-stimulating factor after rituximab in patients with follicular lymphoma
Journal of Clinical Oncology, 06/22/09
Lack of prognostic significance of the germinal-center phenotype in diffuse large B-cell lymphoma patients treated with CHOP-like chemotherapy with and without rituximab
International Journal of Hematology, 06/09/09
Gemcitabine and oxaliplatin combination chemotherapy for metastatic well-differentiated neuroendocrine carcinomas
Cancer, 06/01/09
Article Search
Sponsor


See Latest Articles


